What is MabPlex International?
MabPlex International, founded in 2013, is a fully integrated global Contract Development and Manufacturing Organization (CDMO) specializing in advanced biologics platforms. With extensive R&D and production facilities across China and the United States, MabPlex offers comprehensive solutions from biologics drug development to commercial manufacturing. The company boasts nine monoclonal antibody (mAb) Drug Substance (DS) production lines, two Antibody-drug Conjugate (ADC) DS production lines, and formulation capabilities for both mAbs and ADCs. MabPlex's services are designed to accelerate clinical trial progress and support market launches for its global clientele, having contributed to over 12 Investigational New Drug (IND) approvals with major regulatory bodies including the FDA, TGA, and NMPA.
How much funding has MabPlex International raised?
MabPlex International has raised a total of $59.1M across 1 funding round:
Series A
$59.1M
Series A (2019): $59.1M with participation from State Development & Investment Corporation
Key Investors in MabPlex International
State Development & Investment Corporation
State Development & Investment Corporation (SDIC) is a prominent Chinese state-owned investment company with a broad portfolio in infrastructure and energy. Its involvement suggests a strategic alignment with large-scale industrial development and potentially a focus on supporting key national industries.
What's next for MabPlex International?
The substantial enterprise-level funding MabPlex International has attracted signals a strong growth trajectory and an expansion phase for its operations. This strategic investment is likely to fuel further enhancements in its manufacturing capacity, technological advancements in biologics and ADC development, and potentially broaden its global footprint. The company's focus on accelerating clinical trials and supporting market launches positions it to capitalize on the increasing demand for specialized CDMO services in the pharmaceutical industry.
See full MabPlex International company page
